Author Page for Antonio Rivero

Two-Year Longitudinal Profile of HIV-1 DNA/RNA Integrity, Immune Activation, and Inflammation in Treatment-Naïve People with HIV-1 Starting Dolutegravir/Lamivudine vs. Dolutegravir/Tenofovir Alafenamide/Emtricitabine: TRIDUNA Study

Number of pages: 28 Posted: 09 Dec 2024

Abraham Saborido-Alconchel, Ana Serna-Gallego, María Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana I. Alvarez-Ríos, Cesar Sotomayor, Marta Herrero, Nuria Espinosa, Miguel Raffo Marquez, Alberto Romero, Gabriel Mariscal-Vázquez, Antonio Rivero, Cristina Roca-Oporto, Alicia Gutierrez-Valencia and Luis F. Lopez-Cortes

Virgen del Rocio University, Virgen del Rocio University, Virgen del Rocio University, Virgen del Rocio University, University of Seville, Virgen del Rocio University, Virgen del Rocio University, Virgen del Rocio University, Hospital Juan Ramón Jiménez, University Hospital of Puerto Real, Carlos III Institute of Health, Instituto de Salud Carlos III - CIBER de Enfermedades Infecciosas (CIBERINFEC), Virgen del Rocio University, Virgen del Rocio University and Virgen del Rocio University

Downloads 131 (554,631)

Abstract:

2.

Life Expectancy of People with HIV on Antiretroviral Therapy in Spain

Number of pages: 22 Posted: 18 May 2023

Inma Jarrin, Marta Rava, Jorge del Romero Raposo, Antonio Rivero, Jorge del Romero Guerrero, María de Lagarde, Javier Martínez-Sanz, Gemma Navarro, David Dalmau, José Ramón Blanco, Ana Koerting, Javier Gomez Castellá and Julia del Amo

Carlos III Institute of Health - National Center for Epidemiology, Carlos III Institute of Health - National Center for Epidemiology, Carlos III Institute of Health - National Center for Epidemiology, Instituto de Salud Carlos III - CIBER de Enfermedades Infecciosas (CIBERINFEC), Hospital Clinico San Carlos, Instituto de Salud Carlos III - CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III - CIBER de Enfermedades Infecciosas (CIBERINFEC), Parc Taulí Hospital Universitari - Instituto de Investigación y Innovación (I3PT-CERCA), Hospital Universitario Mutua de Terrassa - Department of Internal Medicine, Hospital San Pedro Centro de Investigación Biomédica de La Rioja (CIBIR), Ministry of Health, Spain - Division of HIV, STI, Hepatitis and Tuberculosis, Ministry of Health, Spain - Division of HIV, STI, Hepatitis and Tuberculosis and Ministry of Health, Spain - Division of HIV, STI, Hepatitis and Tuberculosis

Downloads 89 (747,755)

Abstract:

3.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naïve Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Number of pages: 28 Posted: 27 May 2021

University Hospital of Bellvitge, Hospital Universitario La Paz, University Hospital of Bellvitge, Hospital General Universitario de Alicante, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Hospital Germans Trias i Pujol, Hospital Vall d’Hebron, Universidad de Alcalá, IRYCIS - Department of Infectious Diseases, Alvaro Cunqueiro University Hospital, Universidad Miguel Hernández de Elche, Hospital Universitario Virgen de la Victoria, Hospital Universitari Son Espases, Hospital Universitario Son Llatzer, University of Barcelona - Department of Infectious Diseases, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación, Sanitaria del Hospital Clínico San Carlos (IdISSC), Instituto de Salud Carlos III - CIBER de Enfermedades Infecciosas (CIBERINFEC), Complejo Hospitalario Universitario de Badajoz, Hospital Universitario Reina Sofía, Hospital Universitario San Cecilio de Granada - Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospital del Mar - Department of Infectious Diseases, Hospital infanta Leonor, Hospital Universitario Virgen de Valme, Hospital Universitario y Politecnico La Fe, Hospital de la Princesa, University Hospital of Bellvitge, Red de Investigación en Sida, University Hospital of Bellvitge, Universidad de Barcelona - Hospital Clínic Barcelona and Universidad de Alcalá, IRYCIS

Downloads 66 (907,769)

Antonio Rivero

Instituto de Salud Carlos III - CIBER de Enfermedades Infecciosas (CIBERINFEC)

3

286

0

Scholarly Papers (3)

Two-Year Longitudinal Profile of HIV-1 DNA/RNA Integrity, Immune Activation, and Inflammation in Treatment-Naïve People with HIV-1 Starting Dolutegravir/Lamivudine vs. Dolutegravir/Tenofovir Alafenamide/Emtricitabine: TRIDUNA Study

Abstract:

Life Expectancy of People with HIV on Antiretroviral Therapy in Spain

Abstract:

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naïve Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Abstract: